These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 37796644)
21. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. McPartlin AJ; Dawson LA Cancer J; 2016; 22(4):296-301. PubMed ID: 27441750 [TBL] [Abstract][Full Text] [Related]
22. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma. Kim JW; Seong J; Lee IJ; Woo JY; Han KH Oncotarget; 2016 Jun; 7(26):40756-40766. PubMed ID: 27213593 [TBL] [Abstract][Full Text] [Related]
23. Advances in external beam stereotactic body radiotherapy: principle concerns in implementing a liver radiation program. Gaede S; Lock MI Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S13. PubMed ID: 28917251 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration. Lee S; Kim H; Ji Y; Cho B; Kim SS; Jung J; Kwak J; Park JH; Lee SW; Kim JH; Yoon SM Sci Rep; 2018 Nov; 8(1):16224. PubMed ID: 30385839 [TBL] [Abstract][Full Text] [Related]
25. Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy. Lasley FD; Mannina EM; Johnson CS; Perkins SM; Althouse S; Maluccio M; Kwo P; Cárdenes H Pract Radiat Oncol; 2015; 5(5):e443-e449. PubMed ID: 25899219 [TBL] [Abstract][Full Text] [Related]
26. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment. Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273 [TBL] [Abstract][Full Text] [Related]
27. Conformal and stereotactic radiotherapy in hepatocellular carcinoma. Scorsetti M; Bignardi M Ann Ital Chir; 2008; 79(2):107-10. PubMed ID: 18727272 [TBL] [Abstract][Full Text] [Related]
28. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study. Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972 [TBL] [Abstract][Full Text] [Related]
29. Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease. Jackson WC; Tang M; Maurino C; Mendiratta-Lala M; Parikh ND; Matuszak MM; Dow JS; Cao Y; Mayo CS; Ten Haken RK; Schipper MJ; Cuneo KC; Owen D; Lawrence TS Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):212-219. PubMed ID: 32853708 [TBL] [Abstract][Full Text] [Related]
30. [Hepatic tumors and radiotherapy]. Rio E; Mornex F; Peiffert D; Huertas A Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035 [TBL] [Abstract][Full Text] [Related]
31. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls. Mastrocostas K; Jang HJ; Fischer S; Dawson LA; Munoz-Schuffenegger P; Sapisochin G; Kim TK Abdom Radiol (NY); 2019 May; 44(5):1795-1807. PubMed ID: 30710166 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of radiotherapy for primary liver cancer. Chen W; Chiang CL; Dawson LA Chin Clin Oncol; 2021 Feb; 10(1):9. PubMed ID: 32576017 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies. Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536 [TBL] [Abstract][Full Text] [Related]
35. Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Suresh K; Owen D; Bazzi L; Jackson W; Ten Haken RK; Cuneo K; Feng M; Lawrence TS; Schipper MJ Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):131-137. PubMed ID: 29128147 [TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma. Klein J; Korol R; Lo SS; Chu W; Lock M; Dorth JA; Ellis RJ; Mayr NA; Huang Z; Chung HT Future Oncol; 2014 Nov; 10(14):2227-41. PubMed ID: 25471036 [TBL] [Abstract][Full Text] [Related]
37. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting. Gerum S; Heinz C; Belka C; Walter F; Paprottka PM; De Toni EN; Roeder F Strahlenther Onkol; 2020 Apr; 196(4):334-348. PubMed ID: 31732784 [TBL] [Abstract][Full Text] [Related]
38. Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy? Srivastava A; Parambath HK; Ramdulari AV; Saxena H; Kumar R; Pandey S; Shalimar ; Gupta S; Jee B Int J Radiat Biol; 2022; 98(10):1495-1509. PubMed ID: 35311612 [TBL] [Abstract][Full Text] [Related]
39. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity. Loi M; Comito T; Franzese C; Dominici L; Lo Faro L; Clerici E; Franceschini D; Mancosu P; Reggiori G; Gallo P; Badalamenti M; Scorsetti M J Cancer Res Clin Oncol; 2021 Mar; 147(3):927-936. PubMed ID: 32945972 [TBL] [Abstract][Full Text] [Related]
40. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma. Jun BG; Kim YD; Cheon GJ; Kim ES; Jwa E; Kim SG; Kim YS; Kim BS; Jeong SW; Jang JY; Lee SH; Kim HS Korean J Intern Med; 2018 Nov; 33(6):1093-1102. PubMed ID: 28844122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]